Cargando…
Plant-based vaccines: unique advantages
Numerous studies have shown that viral epitopes and subunits of bacterial toxins can be expressed and correctly processed in transgenic plants. The recombinant proteins induce immune responses and have several benefits over current vaccine technologies, including increased safety, economy, stability...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd.
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127671/ https://www.ncbi.nlm.nih.gov/pubmed/11257418 http://dx.doi.org/10.1016/S0264-410X(00)00512-0 |
_version_ | 1783516411409203200 |
---|---|
author | Streatfield, Stephen J. Jilka, Joseph M. Hood, Elizabeth E. Turner, Debra D. Bailey, Michele R. Mayor, Jocelyne M. Woodard, Susan L. Beifuss, Katherine K. Horn, Michael E. Delaney, Donna E. Tizard, Ian R. Howard, John A. |
author_facet | Streatfield, Stephen J. Jilka, Joseph M. Hood, Elizabeth E. Turner, Debra D. Bailey, Michele R. Mayor, Jocelyne M. Woodard, Susan L. Beifuss, Katherine K. Horn, Michael E. Delaney, Donna E. Tizard, Ian R. Howard, John A. |
author_sort | Streatfield, Stephen J. |
collection | PubMed |
description | Numerous studies have shown that viral epitopes and subunits of bacterial toxins can be expressed and correctly processed in transgenic plants. The recombinant proteins induce immune responses and have several benefits over current vaccine technologies, including increased safety, economy, stability, versatility and efficacy. Antigens expressed in corn are particularly advantageous since the seed can be produced in vast quantities and shipped over long distances at ambient temperature, potentially allowing global vaccination. We have expressed the B-subunit of Escherichia coli heat-labile enterotoxin and the spike protein of swine transmissible gastroenteritis virus at high levels in corn, and demonstrate that these antigens delivered in the seed elicit protective immune responses. |
format | Online Article Text |
id | pubmed-7127671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Elsevier Science Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71276712020-04-08 Plant-based vaccines: unique advantages Streatfield, Stephen J. Jilka, Joseph M. Hood, Elizabeth E. Turner, Debra D. Bailey, Michele R. Mayor, Jocelyne M. Woodard, Susan L. Beifuss, Katherine K. Horn, Michael E. Delaney, Donna E. Tizard, Ian R. Howard, John A. Vaccine Article Numerous studies have shown that viral epitopes and subunits of bacterial toxins can be expressed and correctly processed in transgenic plants. The recombinant proteins induce immune responses and have several benefits over current vaccine technologies, including increased safety, economy, stability, versatility and efficacy. Antigens expressed in corn are particularly advantageous since the seed can be produced in vast quantities and shipped over long distances at ambient temperature, potentially allowing global vaccination. We have expressed the B-subunit of Escherichia coli heat-labile enterotoxin and the spike protein of swine transmissible gastroenteritis virus at high levels in corn, and demonstrate that these antigens delivered in the seed elicit protective immune responses. Elsevier Science Ltd. 2001-03-21 2001-03-14 /pmc/articles/PMC7127671/ /pubmed/11257418 http://dx.doi.org/10.1016/S0264-410X(00)00512-0 Text en Copyright © 2001 Elsevier Science Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Streatfield, Stephen J. Jilka, Joseph M. Hood, Elizabeth E. Turner, Debra D. Bailey, Michele R. Mayor, Jocelyne M. Woodard, Susan L. Beifuss, Katherine K. Horn, Michael E. Delaney, Donna E. Tizard, Ian R. Howard, John A. Plant-based vaccines: unique advantages |
title | Plant-based vaccines: unique advantages |
title_full | Plant-based vaccines: unique advantages |
title_fullStr | Plant-based vaccines: unique advantages |
title_full_unstemmed | Plant-based vaccines: unique advantages |
title_short | Plant-based vaccines: unique advantages |
title_sort | plant-based vaccines: unique advantages |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127671/ https://www.ncbi.nlm.nih.gov/pubmed/11257418 http://dx.doi.org/10.1016/S0264-410X(00)00512-0 |
work_keys_str_mv | AT streatfieldstephenj plantbasedvaccinesuniqueadvantages AT jilkajosephm plantbasedvaccinesuniqueadvantages AT hoodelizabethe plantbasedvaccinesuniqueadvantages AT turnerdebrad plantbasedvaccinesuniqueadvantages AT baileymicheler plantbasedvaccinesuniqueadvantages AT mayorjocelynem plantbasedvaccinesuniqueadvantages AT woodardsusanl plantbasedvaccinesuniqueadvantages AT beifusskatherinek plantbasedvaccinesuniqueadvantages AT hornmichaele plantbasedvaccinesuniqueadvantages AT delaneydonnae plantbasedvaccinesuniqueadvantages AT tizardianr plantbasedvaccinesuniqueadvantages AT howardjohna plantbasedvaccinesuniqueadvantages |